Maryland Vioxx Lawyers
Legal Representation for Pharmaceutical Liability Cases
On September 30, 2004, Merck & Company announced the recall of Vioxx (rofecoxib), a popular medication used to treat osteoarthritis, acute pain conditions and dysmenorrhea. The drug was also marketed under the brand names of Ceoxx and Ceeoxx. The announcement came in the wake of a recent study that showed strong ties between Vioxx and increased risks for heath attack and strokes in patients.
Used to reduce pain, inflammation and stiffness caused by osteoarthritis and rheumatoid arthritis, Vioxx was intended to be an improved version of similar painkillers. Unfortunately, patients began reporting adverse effects after taking the medication. As more studies were conducted, there were significant results that indicated higher risks of adverse cardiovascular side effects associated with the use of Vioxx as compared with other pain relief medications.
In one medical study conducted by the Cleveland Clinic, more than 2,600 arthritis patients were treated and monitored over an 18-month period. Patients using Vioxx were found to be at double the risk for heart attack and stroke than those not using the medication. Until the Cleveland Clinic Study, Merck & Company maintained the Vioxx was safe.
Retain an Experienced Maryland Personal Injury Lawyer
The increased risk for adverse cardiovascular reactions such as heart attacks and strokes pose serious and life-changing consequences to patients who take this medication with the belief that they will find relief and the ability to live a better life. Through an effective application of product liability law and experience in pharmaceutical liability litigation, our firm can work to hold Merck & Company liable for damages Vioxx caused to patients.
If you or a loved one has suffered a heart attack, stroke or any other health complication after taking Vioxx, schedule a free case evaluation with a Maryland personal injury lawyer from our firm to learn more about the ways in which we can fight for your compensation.